Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carboplatin-related idiosyncrasy

M Inbar1, O Merimsky, S Chaitchik

  • 1Department of Oncology, Tel-Aviv University, Israel.

Anti-Cancer Drugs
|December 1, 1995
PubMed
Summary

Carboplatin can cause rare allergic reactions in ovarian cancer patients, presenting as skin rash and breathing difficulties. Prompt treatment with steroids and antihistamines effectively resolved these unique hypersensitivity symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular analysis of feces reveals gastrointestinal nematodes in reintroduced wild asses of the Negev desert.

International journal for parasitology. Parasites and wildlife·2024
Same author

Phase II single-arm study of nivolumab and ipilimumab (Nivo/Ipi) in previously treated classical Kaposi sarcoma (cKS).

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.

ESMO open·2021

Area of Science:

  • Oncology
  • Pharmacology
  • Toxicology

Background:

  • Cisplatin and carboplatin are platinum-based chemotherapy agents widely used in cancer treatment.
  • Common side effects include nausea, vomiting, neuropathy, nephrotoxicity, hearing loss, and bone marrow suppression.
  • Allergic reactions, though rare, can occur with these agents.

Observation:

  • A young woman undergoing treatment for ovarian cancer experienced an unusual reaction to carboplatin.
  • The patient presented with acute symptoms including skin rash, dyspnea (shortness of breath), and facial/truncal erythema.
  • Importantly, hemodynamic stability was maintained, with no significant drop in blood pressure or change in heart rate.

Findings:

  • This case highlights a unique idiosyncratic hypersensitivity reaction to carboplatin.
  • The observed symptoms differed from typical anaphylactic responses, particularly the absence of hypotension.
  • Rapid resolution of symptoms was achieved with the administration of hydrocortisone and promethazine.

Implications:

  • This case underscores the importance of recognizing diverse hypersensitivity reactions to carboplatin.
  • It suggests that prompt intervention with corticosteroids and antihistamines can effectively manage such idiosyncratic reactions.
  • Further investigation into the mechanisms of carboplatin hypersensitivity may inform safer treatment protocols.

Related Experiment Videos